Vistagen Therapeutics (VTGN) EPS (Basic) (2012 - 2026)
Vistagen Therapeutics (VTGN) posted EPS (Basic) of -$0.43 for Q1 2026, up 4.35% sequentially from -$0.45 in Q4 2025, and up 3.0% YoY from -$0.42 in Q1 2025.
Vistagen Therapeutics (VTGN) EPS (Basic) (2012 - 2026) Analysis & Trends
Vistagen Therapeutics has reported EPS (Basic) for 15 years, with the latest figure at -$0.43 in Q1 2026.
- Quarterly EPS (Basic) rose 3.0% year-over-year to -$0.43 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.83 (down 9.97% YoY) and the FY2026 annual result came in at -$1.83, down 9.97% from the prior year.
- EPS (Basic) advanced to -$0.43 in Q1 2026 per VTGN's latest filing, from -$0.45 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.22 in Q4 2023 and troughed at -$2.87 in Q2 2022.
- A 5-year average of -$1.0 and a median of -$0.49 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) tumbled 124.25% in 2022, then surged 84.74% in 2023.
- Over 5 years, EPS (Basic) stood at -$1.42 in 2022, then soared by 84.74% to -$0.22 in 2023, then sank by 112.31% to -$0.46 in 2024, then rose by 2.46% to -$0.45 in 2025, then gained by 4.35% to -$0.43 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.43, -$0.45, and -$0.54 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Vistagen Therapeutics | 10.49 Mn | 10.49 Mn | - | -0.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.43 |
| Dec 31, 2025 | -0.45 |
| Sep 30, 2025 | -0.54 |
| Jun 30, 2025 | -0.47 |
| Mar 31, 2025 | -0.44 |
| Dec 31, 2024 | -0.46 |
| Sep 30, 2024 | -0.42 |
| Jun 30, 2024 | -0.35 |
| Mar 31, 2024 | -0.49 |
| Dec 31, 2023 | -0.22 |
| Sep 30, 2023 | -0.66 |
| Jun 30, 2023 | -0.94 |
| Mar 31, 2023 | -1.76 |
| Dec 31, 2022 | -1.42 |
| Sep 30, 2022 | -2.54 |
| Jun 30, 2022 | -2.87 |
| Mar 31, 2022 | -2.53 |
| Dec 31, 2021 | -1.59 |
| Sep 30, 2021 | -2.04 |
| Jun 30, 2021 | -1.28 |